VG Somani, the Drug Controller General of India said on Monday that Covishield and Covaxin are ''safe and provide a robust immune response.'' India's drugs regulator has given final emergency-use approval for two coronavirus vaccines, Serum Institute of India's Covishield, developed by Oxford University and pharma major AstraZeneca, and Bharat Biotech's Covaxin.

Covishield, Covaxin are safe and provide robust immune response, says Drug Controller General of India VG Somani

drug-controller-general-of-india

Drug Controller General Of India, News on Drug Controller General Of India, stories on Drug Controller General Of India, articles on Drug Controller General Of India, Drug Controller General Of India stories at Wion, Drug Controller General Of India news, Drug Controller General Of India latest news

drug controller-general-of-india

Covishield, Covaxin are safe and provide robust immune response, says Drug Controller General of India VG Somani